Ordinary Index Rebalancing in the Solactive Future Pharmaceutical Europe Index | September 2021

In the ordinary rebalance the following composition will be implemented effective open 07.09.2021:

ARGENX SE
ASTRAZENECA PLC
BAYER AG
EVOTEC SE
GLAXOSMITHKLINE PLC
GRIFOLS SA CLASS A
IPSEN SA
MERCK KGAA
NOVARTIS AG
NOVO NORDISK A/S
RECORDATI SPA
ROCHE HOLDING AG
SANOFI SA
UCB SA
VIFOR PHARMA AG